Dr Jonathan Krell, Consultant Oncologist

Dr Jonathan Krell

Consultant Oncologist

Book online
|

Dr Jonathan Krell

Consultant Oncologist

Dr Jonathan Krell

Consultant Oncologist

Book online
|

Areas of expertise

  • Gynaecological cancers (cancers of the ovary, fallopian tube, cervix, uterus and primary peritoneal cancers)
  • Chemotherapy
  • Genetic testing
  • Breast cancer
  • Ovarian cancer

Recommendations for Dr Krell

These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.

Recommended by:

  • byDr James Mackay, Consultant Clinical Genetic Oncologist

    Dr Jonathan Krell is a specialist in GI cancer.

  • byDr James Mackay, Consultant Clinical Genetic Oncologist

    Dr Jonathan Krell is a specialist in GI cancer.

  • Address

    • LOC at Chelsea

      102 Sydney Street, Chelsea, London, SW3 6NJ

    • LOC - Leaders in Oncology Care

      95-97 Harley Street, London, W1G 6AF

    • The Lister Hospital

      Chelsea Bridge Road, London, SW1W 8RH

    • The Wellington Hospital

      Wellington Place, St John's Wood, London, NW8 9LE

    About Dr Jonathan Krell

    GMC number: 6075165

    Year qualified: 2003

    Place of primary qualification: University of Leeds

    Areas of expertise

    • Breast cancer
    • Gynaecological cancer
    • Urological cancer

    Professional memberships

    Cancer Research UK
    Ovarian Cancer Action
    General Medical Council

    Articles by Dr Jonathan Krell

    The clinical use of circulating tumor cells (ctcs) enumeration for staging of metastatic breast cancer (mbc): international expert consensus paper

    Correction: does molecular profiling of tumors using the caris molecular intelligence platform improve outcomes for cancer patients?

    Correction: assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy

    Author correction: tgf-β induces mir-100 and mir-125b but blocks let-7a through lin28b controlling pdac progression

    Size-exclusion chromatography as a technique for the investigation of novel extracellular vesicles in cancer

    Correction: the benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas

    Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plans

    Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden

    Tgf-β induces mir-100 and mir-125b but blocks let-7a through lin28b controlling pdac progression

    The role of circular rnas in pancreatic ductal adenocarcinoma and biliary-tract cancers